| MBRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MBRX market cap history going back to 6/2/2016:
Also see: MBRX Shares Outstanding History and MBRX YTD Return |
MBRX Market Cap History — Moleculin Biotech Capitalization Over Time
As of 5/7/2026 Moleculin Biotech has a market cap of 13.29 million. Investors often follow the MBRX market cap history to compare the size of the company over time.
This page shows MBRX market capitalization trends over time, with 45 market cap datapoints presented, dating back to 6/2/2016.
| MBRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MBRX Historical Market Cap: -17.46% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MBRX Stock Price Chart |
| About Moleculin Biotech Inc |
| Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. Co. has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. We show 45 historical shares outstanding datapoints in our MBRX shares outstanding history coverage, used to compute MBRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MBRX market cap history over the course of time is important for investors interested in comparing MBRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MBRX versus a peer is one thing; comparing MBRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MBRX can fluctuate over the course of history. With this page we aim to empower investors researching MBRX by allowing them to research the MBRX market cap history. |
| MBRX Current Stock Quote |
Quotes delayed 20 minutes  Free MBRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| MBRX Share Performance |
| Market Cap Peers |
| Moleculin Biotech (MBRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MBVX Market Cap History MCK Market Cap History MCRB Market Cap History MD Market Cap History MDCO Market Cap History MDGL Market Cap History MDT Market Cap History MDXG Market Cap History ME Market Cap History MEDP Market Cap History More Healthcare companies » |
MBRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
